Gapping down
In reaction to disappointing earnings/guidance:
- PSO -16.5% (provides updated guidance for first nine months of 2019; sees flat sales growth) FUL -5.8%, FDS -3.7%, ACN -1.2%
Other news:
- ENTA -21.6% (announces "positive" results of ARGON-1 study of its lead FXR Agonist, EDP-305, for the treatment of NASH)
- BTAI -10.8% (commences underwritten public offering of $19.0 mln shares of common stock)
- PLYM -6.9% (prices offering of 3 mln shares of common stock at $18.00 per share)
- CTRP -4.5% (commencement of offering of an aggregate of 31,304,352 American depositary shares by shareholder Baidu (BIDU))
- FOR -2.3% (prices offering of 5.25 mln shares of common stock at $17.50 per share)
- ERIC -2.1% (makes SEK 12 bln provision related to resolving SEC/DOJ investigations)
Analyst comments:
- HDS -1.6% (downgraded to Mkt Perform from Outperform at William Blair)
- HRI -2.1% (downgraded to Neutral from Buy at BofA/Merrill)
- HDS -1.6% (downgraded to Equal Weight from Overweight at Barclays)
- TKR -1.3% (downgraded to Underperform from Neutral at BofA/Merrill)